Monday, 2016/08/08
Session 1: EBV epidemiology and sequence variation 2:30pm-
Chairpersons:
Henri-Jacques Delecluse, German Cancer Research Institute, Heidelberg, Germany
Alan Chiang, University of Hong Kong, China
- Heterogeneity of the major internal repeat (IR1) of Epstein-Barr virus implicates interstrain recombination in pathogenesis, and includes a nonsense mutation of EBNA-LP in the prototype strain B95-8. Mohammed Ba Abdullah, Imperial College London, UK
- High levels of antibody that neutralize B-cell infection of Epstein-Barr virus and that bind EBV gp350 are associated with a lower risk of nasopharyngeal carcinoma Anna Coghill, National Cancer Institute, Bethesda, USA
- Development of highly efficient and widely applicable CRISPR/Cas9-mediated cloning method of EBV genomes and its application to EBV-positive gastric cancer cell lines Teru Kanda, Aichi Cancer Center Research Institute, Nagoya, Japan
- Association between cigarette smoking and oral EBV viral loads in China: a multicenter cross sectional study in 2013-2016 Weihua Jia, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Determination and Genome-wide Analysis of EBV Sequences in EBV- associated Gastric Carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma Chun-kui Shao, Sun Yat-Sen University, Guangzhou, China
- The dominating promoter variation of BRLF1 in nasopharyngeal carcinoma endemic area contributes to high efficacy of Epstein-Barr virus reactivation Jiangbo Zhang, Sun Yat-Sen University Cancer Center, Guangzhou, China
